MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Gastric Cancer Management and Outcomes
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,089 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,089 works in the cohort · of 4,299,418page 4 of 22

Labels cover 5 of 1,089 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,089 of 1,089 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Controversies in EUS: Do we need miniprobes?
ChristophF Dietrich, H Seifert, Pietro Fusaroli, Paolo Giorgio Arcidiacono, Barbara Braden, Felix Herth +7 more
2021· article· en· Endoscopic Ultrasound· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
33
citations
affunlabeled
Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study.
Yelena Y. Janjigian, Salah‐Eddin Al‐Batran, Zev A. Wainberg, Eric Van Cutsem, Daniela Molena, Kei Muro +14 more
2024· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
32
citations
affunlabeled
CheckMate 649: A randomized, multicenter, open-label, phase III study of nivolumab (NIVO) + ipilimumab (IPI) or nivo + chemotherapy (CTX) versus CTX alone in patients with previously untreated advanced (Adv) gastric (G) or gastroesophageal junction (GEJ) cancer.
Markus Moehler, Yelena Y. Janjigian, Antoine Adenis, Jean-Sebastien Aucoin, Narikazu Boku, Ian Chau +11 more
2018· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
30
citations
affunlabeled
On the use and abuse of X in the TNM classification
Frederick L. Greene, James D. Brierley, Brian O’Sullivan, Leslie H. Sobin, Christian Wittekind
2004· article· en· Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
28
citations
← previousnext →

How this was built: Screen · Findings · About